TABLE 3.

Comparisons of VR indicators in mice treated with miR-9 agomir or in combination with oe-SDC2.

Groups	MT	LD	MT/LD (%)
agomir NC	70.05 ± 10.02	2.91 ± 0.56	24.69 ± 5.41
miR-9 agomir	34.91 ± 2.79*	7.13 ± 0.28*	4.90 ± 0.43*
miR-9 agomir + oe-SDC2	68.26 ± 9.62	3.12 ± 0.25	23.76 ± 4.45

miR-9, microRNA-9; VR, vascular remodeling; MT, medium wall thickness; LD, lumen diameter; MT/LD, medium wall thickness/lumen diameter; NC, negative control; *p < 0.05 vs. mice treated with agomir NC; n = 8 for mice upon each treatment; All data were measurement data and expressed as mean ± standard deviation. Comparisons were analyzed using the unpaired t-test. The experiment was repeated 3 times.